The Accelerated Access Collaborative has delayed its Board meeting (scheduled at the end of April) without confirming a new date. This is because the Chair of the AAC, Sir Andrew Witty, has decided to step down. The meeting will go ahead once a new Chair has been appointed, which is likely to happen in the next few weeks.
The AAC closed its first call for nominations on 9 March 2018, and will review those products at its Board meeting. The Accelerated Access Collaborative (AAC) was established as part of the Government’s response to the Accelerated Access Review, and is currently developing it’s working procedures. The AAC will select a small number of transformative products, likely between one and five, across medicines, devices, diagnostics and digital to begin working with to help speed up the formalisation of their processes.